Yang SW et al. |
MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells. |
2016 |
Drug Des Devel Ther |
pmid:27382252
|
Chiang KC et al. |
The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential. |
2016 |
Int J Mol Sci |
pmid:27110769
|
Chiang KC et al. |
MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro. |
2014 |
J. Steroid Biochem. Mol. Biol. |
pmid:24125734
|
Yasuda K et al. |
Human cytochrome P450-dependent differential metabolism among three 2α-substituted-1α,25-dihydroxyvitamin D(3) analogs. |
2013 |
J. Steroid Biochem. Mol. Biol. |
pmid:22982757
|
Chiang KC et al. |
MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase. |
2013 |
J. Steroid Biochem. Mol. Biol. |
pmid:24044969
|
Chiang KC et al. |
Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo. |
2013 |
Cell Cycle |
pmid:23549173
|
Chiang KC et al. |
19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells. |
2011 |
Steroids |
pmid:21888924
|
|
|
|
|
pmid:
|
|
|
|
|
pmid:25918960
|
|
|
|
|
pmid:26282787
|